Gladstone NOW: The Campaign Join Us on the Journey✕
1 - 8 of 8 Results Clear All
The single-dose, intranasal treatment also reduces symptoms of multiple variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Center for Cell Circuitry Virology Weinberger Lab Chaturvedi
New class of resistance-proof drugs could one day transform treatments for viral diseases
News Release Research (Publication) Center for Cell Circuitry Virology Weinberger Lab Chaturvedi
The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Huang Lab Ott Lab Pollard Lab Srivastava Lab Weinberger Lab
Gladstone discoveries compete head-to-head with other scientific advancements
Awards COVID-19 Traumatic Brain Injury Alzheimer’s Disease Huang Lab Paz Lab Weinberger Lab Chaturvedi
Gladstone scientists develop a single-dose intranasal treatment that is effective against variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Virology Weinberger Lab Chaturvedi
Gladstone researchers discover a fundamental mechanism that appears to speed the change of stem cells into other cell types
News Release Research (Publication) Virology Weinberger Lab Stem Cells/iPSCs Chaturvedi
Varying levels of proteins in cytomegalovirus particles help the virus survive in different conditions.
News Release Research (Publication) Flow Cytometry Core Virology Weinberger Lab Basic Science Chaturvedi
New study uncovers how the viruses bypass your body’s defense mechanisms
News Release Research (Publication) Center for Cell Circuitry Virology Weinberger Lab Chaturvedi
